ICTEX Performance — ICON Health and Information Technology Fund, Institutional Class
Data updated: 2026-08-31
ICTEX returned +33.11% year to date and +48.91% over one year to Jun 2026. Annualised returns are +24.08% over 3 years and +8.82% over 5 years. Against its Technology Equity category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $191, against $225 for the category, and to $149 over one year, against $146. Volatility over the past three years was 18.51% a year. In the 12 months to Jun 2026 the fund lost a net $4.9M, and assets reached $97.77M.
ICTEX Growth of $100
What $100 invested in ICON Health and Information Technology Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Technology Equity category average over the same months.
| Period | ICTEX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $149 | $146 |
| 3 years (Jul 2023 – Jun 2026) | $191 | $225 |
| 5 years (Jul 2021 – Jun 2026) | $153 | $201 |
| Since data start (Jul 2020 – Jun 2026) | $219 | $299 |
ICTEX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +33.11% |
| 1 year | +48.91% |
| 3 years (annualised) | +24.08% |
| 5 years (annualised) | +8.82% |
ICTEX Annual Returns
Calendar-year total returns of ICON Health and Information Technology Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +33.11% |
| 2025 | +17.32% |
| 2024 | +13.74% |
| 2023 | +10.88% |
| 2022 | −25.62% |
| 2021 | +17.35% |
| 2020 (Jul–Dec) | +27.69% |
ICTEX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.8% | +0.4% | −6.5% | +18.7% | +8.7% | +3.9% | — | — | — | — | — | — |
| 2025 | −8.8% | −8.3% | +6.6% | +7.3% | +7.1% | +2.3% | +6.3% | +3.3% | −0.4% | +5.0% | −2.2% | −0.4% |
| 2024 | +2.6% | +4.6% | +0.9% | +3.9% | +2.7% | −5.5% | +0.7% | +2.4% | +2.4% | −2.3% | +4.8% | −3.5% |
| 2023 | 0.0% | 0.0% | 0.0% | +3.4% | −0.1% | −0.2% | −3.8% | 0.0% | +1.0% | +5.4% | +7.6% | −2.4% |
| 2022 | +1.6% | −4.6% | −7.3% | −8.1% | +2.9% | −9.3% | −7.1% | −3.9% | +8.0% | 0.0% | 0.0% | +0.1% |
| 2021 | +2.8% | +2.0% | −0.1% | +2.0% | 0.0% | +5.5% | −7.8% | 0.0% | +2.9% | +6.9% | −2.2% | +5.0% |
| 2020 | — | — | — | — | — | — | −4.7% | +5.6% | +7.0% | +6.2% | +15.2% | −3.1% |
ICTEX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 18.51%
- 3-year Sharpe ratio: 1.06 (vs 4.5% risk-free rate)
- Best month: +18.69% (Apr 2026)
- Worst month: −8.79% (Jan 2025)
ICTEX Fund Flows
Monthly money in and out of ICON Health and Information Technology Fund, from SEC Form N-PORT.
- 12-month net flow: −$4.9M
- 12-month gross sales (incl. reinvestments): $1.9M
- Sales ÷ redemptions: 0.28×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $0 | $0 | $0 |
| May 2026 | $0 | $0 | $0 |
| Apr 2026 | $0 | $0 | $0 |
| Mar 2026 | $486K | $890K | −$404K |
| Feb 2026 | $628K | $1.5M | −$842K |
| Jan 2026 | $574K | $1.8M | −$1.3M |
| Dec 2025 | $171K | $211K | −$39K |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $0 | $0 | $0 |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $0 | $0 | $0 |
| Jul 2025 | $39K | $2.3M | −$2.3M |
ICTEX Assets Under Management
Net assets of ICON Health and Information Technology Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $97.77M |
| 2026-03-31 | $74.66M |
| 2025-12-31 | $77.54M |
| 2025-09-30 | $80.42M |
| 2025-06-30 | $77.95M |
| 2025-03-31 | $69.68M |
| 2024-12-31 | $80.58M |
| 2024-09-30 | $85.06M |
| 2024-06-30 | $87.73M |
| 2024-03-31 | $92.33M |
| 2023-12-31 | $88.51M |
| 2023-09-30 | $84.88M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.